Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Duloxetine 60 mg Once Daily versus Placebo in Patients with Chronic Low Back Pain
2008-002248-40Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic low back pain (CLBP) and lumbodynia (LBP) comparing Duloxetine 60 mg once daily with Placebo (2 arms). Primary endpoint: Brief Pain Inventory (BPI) 24-hour average pain score. Started Jun 2008; status: completed.
02
Drugs
duloxetine
03
Conditions
chronic low back pain (CLBP)lumbodynia (LBP)
Beyond the preview
Go deeper on 2008-002248-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002248-40.